Bismuth subsalicylate Withdrawn Phase 4 Trials for Clostridium Difficile Infection (CDI) Treatment

IndicationsStatusPurposePhase
WithdrawnTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03592082Use of Bismuth Subsalicylate in Clostridium Difficile Colitis